News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
24,354 Results
Type
Article (841)
Company Profile (22)
Press Release (23491)
Section
Business (11862)
Career Advice (23)
Deals (1452)
Drug Development (2147)
FDA (363)
Job Trends (777)
News (15449)
Policy (858)
Tag
Academia (123)
Academic (1)
Allergies (3)
Alliances (1249)
ALS (8)
Alzheimer's disease (47)
Antibody-drug conjugate (ADC) (8)
Approvals (377)
Artificial intelligence (9)
Autoimmune disease (3)
Automation (1)
Bankruptcy (10)
Best Places to Work (765)
Biosimilars (12)
Biotechnology (18)
Bladder cancer (2)
Brain cancer (1)
Breast cancer (31)
Cancer (124)
Cardiovascular disease (20)
Career advice (13)
CAR-T (3)
Cell therapy (11)
Clinical research (1880)
Collaboration (22)
Compensation (18)
COVID-19 (63)
CRISPR (1)
C-suite (4)
Cystic fibrosis (4)
Data (158)
Depression (2)
Diabetes (11)
Diagnostics (287)
Drug discovery (3)
Duchenne muscular dystrophy (1)
Earnings (9980)
Events (2972)
Executive appointments (8)
FDA (513)
Fibrodysplasia Ossificans Progressiva (2)
Funding (13)
Gene editing (4)
Generative AI (1)
Gene therapy (12)
GLP-1 (29)
Government (151)
Guidances (107)
Healthcare (1228)
HIV (1)
IgA nephropathy (3)
Immunology and inflammation (9)
Immuno-oncology (1)
Indications (6)
Infectious disease (70)
Inflammatory bowel disease (3)
Influenza (5)
Intellectual property (6)
Interviews (8)
IPO (1034)
Job creations (43)
Job search strategy (13)
Labor market (1)
Layoffs (6)
Legal (162)
Liver cancer (2)
Longevity (1)
Lung cancer (9)
Lymphoma (16)
Machine learning (1)
Manufacturing (12)
MASH (6)
Medical device (761)
Medtech (765)
Mergers & acquisitions (427)
Metabolic disorders (27)
Multiple sclerosis (4)
Neurodegenerative disease (5)
Neuropsychiatric disorders (1)
Neuroscience (75)
NextGen: Class of 2026 (431)
Non-profit (172)
Obesity (9)
Ovarian cancer (5)
Pancreatic cancer (9)
Parkinson's disease (4)
Patents (5)
Patient recruitment (4)
Peanut (2)
People (1127)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (515)
Phase 2 (708)
Phase 3 (679)
Pipeline (414)
Postmarket research (151)
Preclinical (204)
Prostate cancer (5)
Psychedelics (1)
Radiopharmaceuticals (4)
Rare diseases (16)
Real estate (166)
Regulatory (629)
Reports (4)
Research institute (213)
Resumes & cover letters (6)
RSV (1)
Schizophrenia (5)
Series A (3)
Series B (2)
Service/supplier (1)
Special edition (1)
Spinal muscular atrophy (1)
Sponsored (1)
Startups (77)
Supply chain (2)
Vaccines (20)
Venture capital (1)
Weight loss (5)
Women's health (2)
Date
Today (5)
Last 7 days (16)
Last 30 days (43)
Last 365 days (1136)
2026 (51)
2025 (1157)
2024 (1374)
2023 (1569)
2022 (1802)
2021 (1905)
2020 (1675)
2019 (1298)
2018 (5268)
2017 (744)
2016 (438)
2015 (669)
2014 (449)
2013 (343)
2012 (314)
2011 (418)
2010 (507)
Location
Africa (15)
Alabama (2)
Arizona (6)
Asia (1805)
Australia (146)
California (418)
Canada (165)
China (22)
Colorado (18)
Connecticut (17)
Delaware (9)
Europe (2927)
Florida (100)
Georgia (21)
Idaho (1)
Illinois (48)
India (1)
Indiana (26)
Japan (12)
Kansas (4)
Kentucky (1)
Louisiana (6)
Maine (3)
Maryland (47)
Massachusetts (247)
Michigan (8)
Minnesota (29)
Missouri (6)
Montana (1)
Nevada (3)
New Hampshire (14)
New Jersey (123)
New York (99)
North Carolina (73)
Northern California (180)
Ohio (8)
Pennsylvania (102)
South America (26)
Southern California (205)
Tennessee (2)
Texas (44)
United States (1505)
Utah (17)
Virginia (4)
Washington State (30)
Wisconsin (4)
24,354 Results for "191".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease
February 8, 2026
·
7 min read
Press Releases
Novo Nordisk A/S: CagriSema demonstrated superior HbA1c reduction of 1.91%-points and weight loss of 14.2% in adults with type 2 diabetes in the REIMAGINE 2 trial
February 3, 2026
·
6 min read
Press Releases
Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference
October 24, 2025
·
9 min read
Press Releases
Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference
October 14, 2025
·
7 min read
Press Releases
uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease
September 8, 2025
·
7 min read
Press Releases
Synthetic Biology Market Size Poised to Surge $191.48 Bn at 25.04% CAGR by 2034
February 12, 2025
·
1 min read
Press Releases
Synthetic Biology Market Size Poised to Surge $191.48 Bn in 2034 at 25.04% CAGR by 2034
February 10, 2025
·
1 min read
Press Releases
Pyoderma Gangrenosum Market Size to Reach USD 191.8 Million by 2035, Impelled by Advancements in Targeted Therapy
February 13, 2025
·
8 min read
Press Releases
Non-alcoholic fatty liver disease (NAFLD) Market to Reach USD 19.1 Million by 2035, Impelled by Advancements in Diagnostic Techniques
February 5, 2025
·
13 min read
Press Releases
uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease
September 23, 2024
·
5 min read
1 of 2,436
Next
